Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78))

Peter Pickkers; Derek C. Angus; Kristie Bass; Rinaldo Bellomo; Erik van den Berg; Juliane Bernholz; Morten H. Bestle; Kent Doi; Chistopher J. Doig; Ricard Ferrer; Bruno Francois; Henrik Gammelager; Ulf Goettrup Pedersen; Eric Hoste; Susanne Iversen; Michael Joannidis; John A. Kellum; Kathleen Liu; Melanie Meersch; Ravindra Mehta; Scott Millington; Patrick T. Murray; Alistair Nichol; Marlies Ostermann; Ville Pettilä; Christoffer Solling; Matthias Winkel; Paul J. Young; Alexander Zarbock; on behalf of the REVIVAL investigators

doi:10.1007/s00134-024-07357-z

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78))

Peter Pickkers, Derek C. Angus, Kristie Bass, Rinaldo Bellomo, Erik van den Berg, Juliane Bernholz, Morten H. Bestle, Kent Doi, Chistopher J. Doig, Ricard Ferrer, Bruno Francois, Henrik Gammelager, Ulf Goettrup Pedersen, Eric Hoste, Susanne Iversen, Michael Joannidis, John A. Kellum, Kathleen Liu, Melanie Meersch, Ravindra MehtaScott Millington, Patrick T. Murray, Alistair Nichol, Marlies Ostermann, Ville Pettilä, Christoffer Solling, Matthias Winkel, Paul J. Young, Alexander Zarbock, on behalf of the REVIVAL investigators

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	614-615
Number of pages	2
Journal	Intensive Care Medicine
Volume	50
Issue number	4
DOIs	https://doi.org/10.1007/s00134-024-07357-z
Publication status	Published - 1 Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00134-024-07357-zLicence: CC BY-NC

Cite this

Pickkers, P., Angus, D. C., Bass, K., Bellomo, R., van den Berg, E., Bernholz, J., Bestle, M. H., Doi, K., Doig, C. J., Ferrer, R., Francois, B., Gammelager, H., Pedersen, U. G., Hoste, E., Iversen, S., Joannidis, M., Kellum, J. A., Liu, K., Meersch, M., ... on behalf of the REVIVAL investigators (2024). Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78)). Intensive Care Medicine, 50(4), 614-615. https://doi.org/10.1007/s00134-024-07357-z

@article{bcb3cc7ed3c64df5810bcb5ca4fd33e7,

title = "Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78))",

author = "Peter Pickkers and Angus, {Derek C.} and Kristie Bass and Rinaldo Bellomo and {van den Berg}, Erik and Juliane Bernholz and Bestle, {Morten H.} and Kent Doi and Doig, {Chistopher J.} and Ricard Ferrer and Bruno Francois and Henrik Gammelager and Pedersen, {Ulf Goettrup} and Eric Hoste and Susanne Iversen and Michael Joannidis and Kellum, {John A.} and Kathleen Liu and Melanie Meersch and Ravindra Mehta and Scott Millington and Murray, {Patrick T.} and Alistair Nichol and Marlies Ostermann and Ville Pettil{\"a} and Christoffer Solling and Matthias Winkel and Young, {Paul J.} and Alexander Zarbock and {on behalf of the REVIVAL investigators}",

year = "2024",

month = apr,

day = "1",

doi = "10.1007/s00134-024-07357-z",

language = "English",

volume = "50",

pages = "614--615",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer-Verlag London Ltd.",

number = "4",

}

Pickkers, P, Angus, DC, Bass, K, Bellomo, R, van den Berg, E, Bernholz, J, Bestle, MH, Doi, K, Doig, CJ, Ferrer, R, Francois, B, Gammelager, H, Pedersen, UG, Hoste, E, Iversen, S, Joannidis, M, Kellum, JA, Liu, K, Meersch, M, Mehta, R, Millington, S, Murray, PT, Nichol, A, Ostermann, M, Pettilä, V, Solling, C, Winkel, M, Young, PJ, Zarbock, A & on behalf of the REVIVAL investigators 2024, 'Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78))', Intensive Care Medicine, vol. 50, no. 4, pp. 614-615. https://doi.org/10.1007/s00134-024-07357-z

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78)). / Pickkers, Peter; Angus, Derek C.; Bass, Kristie et al.
In: Intensive Care Medicine, Vol. 50, No. 4, 01.04.2024, p. 614-615.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Correction

T2 - Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78))

AU - Pickkers, Peter

AU - Angus, Derek C.

AU - Bass, Kristie

AU - Bellomo, Rinaldo

AU - van den Berg, Erik

AU - Bernholz, Juliane

AU - Bestle, Morten H.

AU - Doi, Kent

AU - Doig, Chistopher J.

AU - Ferrer, Ricard

AU - Francois, Bruno

AU - Gammelager, Henrik

AU - Pedersen, Ulf Goettrup

AU - Hoste, Eric

AU - Iversen, Susanne

AU - Joannidis, Michael

AU - Kellum, John A.

AU - Liu, Kathleen

AU - Meersch, Melanie

AU - Mehta, Ravindra

AU - Millington, Scott

AU - Murray, Patrick T.

AU - Nichol, Alistair

AU - Ostermann, Marlies

AU - Pettilä, Ville

AU - Solling, Christoffer

AU - Winkel, Matthias

AU - Young, Paul J.

AU - Zarbock, Alexander

AU - on behalf of the REVIVAL investigators

PY - 2024/4/1

Y1 - 2024/4/1

UR - http://www.scopus.com/inward/record.url?scp=85190753980&partnerID=8YFLogxK

U2 - 10.1007/s00134-024-07357-z

DO - 10.1007/s00134-024-07357-z

M3 - Comment / Debate

C2 - 38436728

AN - SCOPUS:85190753980

SN - 0342-4642

VL - 50

SP - 614

EP - 615

JO - Intensive Care Medicine

JF - Intensive Care Medicine

IS - 4

ER -

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive care medicine (2024) 50 1 (68-78))

UN SDGs

Access to Document

Other files and links

Research output

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Cite this